StockNews.com Begins Coverage on XBiotech (NASDAQ:XBIT)

StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance Shares of XBiotech stock opened at $5.90 on Thursday. XBiotech has a 52-week low of $3.05 and a 52-week high of $6.69. The […]

Related Keywords

Switzerland ,Swiss , ,Dimensional Fund Advisors ,Charles Schwab Investment Management Inc ,York Mellon Corp ,Xbiotech Inc ,Swiss National Bank ,Jpmorgan Chase Co ,Free Report ,National Bank ,New York Mellon Corp ,Fund Advisors ,Charles Schwab Investment Management ,Schwab Investment Management ,Get Free Report ,True Human ,Xbiotech ,Nasdaq Xbit ,Taxbit ,Medical ,Initiated Coverage ,Stocknews Com ,